Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma-Reference-Cited by-同舟云学术

Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma

Published:2011-12 Issue:12 Volume:19 Page:2258-2268
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Gerdemann Ulrike,Katari Usha,Christin Anne S,Cruz Conrad R,Tripic Tamara,Rousseau Alexandra,Gottschalk Stephen M,Savoldo Barbara,Vera Juan F,Heslop Helen E,Brenner Malcolm K,Bollard Catherine M,Rooney Cliona M,Leen Ann M

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference49 articles.

1. Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer;Bollard;Blood,2007

2. Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients;Heslop;Blood,2010

3. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes;Rosenberg;Science,1986

4. Treatment of nasopharyngeal carcinoma with Epstein-Barr virus–specific T lymphocytes;Straathof;Blood,2005

5. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity;Gulley;Blood,1994

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing;Cytotherapy;2024-03

2. Clinical Experiences with TAA ‐T in Lymphoid Malignancies;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

3. Advances in Cancer Vaccine Research;ACS Biomaterials Science & Engineering;2023-11-03

4. Targeted cellular therapy for treatment of relapsed or refractory leukemia;Best Practice & Research Clinical Haematology;2023-09

5. Engineered tumor-specific T cells using immunostimulatory photothermal nanoparticles;Cytotherapy;2023-07